Behavioral pharmacology of designer cathinones: A review of the preclinical literature

被引:34
作者
Gregg, Ryan A.
Rawls, Scott M.
机构
[1] Temple Univ, Sch Med, Ctr Substance Abuse Res, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA
关键词
Bath salts; Mephedrone; MDPV; Methylone; Locomotor; Psychostimulant; Cathinone; Amphetamine; Pyrovalerone; PSYCHOACTIVE BATH SALTS; MEPHEDRONE; 4-METHYLMETHCATHINONE; AMBIENT-TEMPERATURE; 3,4-METHYLENEDIOXYPYROVALERONE MDPV; PRINCIPAL CONSTITUENT; LOCOMOTOR-ACTIVITY; D-METHAMPHETAMINE; RATS; DOPAMINE; MDMA;
D O I
10.1016/j.lfs.2013.10.033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
"Bath salts" is one street name for a family of synthetic cathinones that display pharmacological effects resembling cocaine and commonly abused amphetamines. Despite extensive legislation aimed at the criminalization of bath salts, several designer cathinones are gaining a foothold in the illicit drug scene; for example, in the United Kingdom, mephedrone (4-methylmethcathinone,MEPH) is highly popular among drug abusers whereas, in the United States, MDPV (methylenedioxypyrovalerone) and methylone are highly prevalent. To date, knowledge about the hazards of designer cathinones is based mostly on hospital reports and anecdotal evidence derived from online surveys. Despite the paucity of preclinical studies directed toward designer cathinones, a number of invaluable findings arising from those studies are enabling scientists to develop their neuropharmacological profiles. Despite their commonalities in chemical structures, synthetic cathinones possess distinct neuropharmacological profiles and produce different behavioral effects, including unique effects on locomotor activity, learning, anxiety, thermoregulation, and abuse liability. The present review will discuss the behavioral effects of MEPH, MDPV, and methylone and compare those effects to established psychostimulant drugs. The rise in the use of designer cathinones in the United States and abroad justifies further investigations into these compounds, both for a greater understanding of the danger that "bath salts" pose to the public, and to provide insight into replacement cathinones as they emerge onto the market. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:27 / 30
页数:4
相关论文
共 55 条
  • [1] The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats
    Aarde, S. M.
    Huang, P. K.
    Creehan, K. M.
    Dickerson, T. J.
    Taffe, M. A.
    [J]. NEUROPHARMACOLOGY, 2013, 71 : 130 - 140
  • [2] Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats
    Aarde, Shawn M.
    Angrish, Deepshikha
    Barlow, Deborah J.
    Wright, M. Jerry, Jr.
    Vandewater, Sophia A.
    Creehan, Kevin M.
    Houseknecht, Karen L.
    Dickerson, Tobin J.
    Taffe, Michael A.
    [J]. ADDICTION BIOLOGY, 2013, 18 (05): : 786 - 799
  • [3] Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA
    Angoa-Perez, Mariana
    Kane, Michael J.
    Briggs, Denise I.
    Francescutti, Dina M.
    Sykes, Catherine E.
    Shah, Mrudang M.
    Thomas, David M.
    Kuhn, Donald M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2013, 125 (01) : 102 - 110
  • [4] Mephedrone, an abused psychoactive component of bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum
    Angoa-Perez, Mariana
    Kane, Michael J.
    Francescutti, Dina M.
    Sykes, Katherine E.
    Shah, Mrudang M.
    Mohammed, Abiy M.
    Thomas, David M.
    Kuhn, Donald M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2012, 120 (06) : 1097 - 1107
  • [5] [Anonymous], 2012, Basic Statistics | Statistics and Surveillance | Topics | CDC HIV/AIDS, P1
  • [6] [Anonymous], MEPHEDRONE REPORT
  • [7] Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products
    Baumann, Michael H.
    Partilla, John S.
    Lehner, Kurt R.
    Thorndike, Eric B.
    Hoffman, Alexander F.
    Holy, Marion
    Rothman, Richard B.
    Goldberg, Steven R.
    Lupica, Carl R.
    Sitte, Harald H.
    Brandt, Simon D.
    Tella, Srihari R.
    Cozzi, Nicholas V.
    Schindler, Charles W.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 (04) : 552 - 562
  • [8] The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
    Baumann, Michael H.
    Ayestas, Mario A., Jr.
    Partilla, John S.
    Sink, Jacqueline R.
    Shulgin, Alexander T.
    Daley, Paul F.
    Brandt, Simon D.
    Rothman, Richard B.
    Ruoho, Arnold E.
    Cozzi, Nicholas V.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2012, 37 (05) : 1192 - 1203
  • [9] Bonano J., 2013, PSYCHOPHARM IN PRESS
  • [10] Analyses of second-generation 'legal highs' in the UK: Initial findings
    Brandt, Simon D.
    Sumnall, Harry R.
    Measham, Fiona
    Cole, Jon
    [J]. DRUG TESTING AND ANALYSIS, 2010, 2 (7-8) : 377 - 382